STOCK TITAN

[Form 4] Blade Air Mobility, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Amir Cohen, Chief Accounting Officer and director of Strata Critical Medical, Inc. (SRTA), reported a grant of 11,844 fully vested restricted stock units (RSUs) on 08/29/2025. The RSUs vest and will be settled in shares of the issuer's Class A common stock at no cash price ($0). Following this transaction, Mr. Cohen beneficially owns 103,760 shares. The RSU grant is effective upon completion of the issuer's previously disclosed sale of its Passenger business to Joby Aero, Inc. under an Equity Purchase Agreement dated August 1, 2025. The Form 4 was signed by attorney-in-fact Melissa M. Tomkiel on 09/03/2025.

Amir Cohen, Chief Accounting Officer e membro del consiglio di amministrazione di Strata Critical Medical, Inc. (SRTA), ha ricevuto in data 29/08/2025 una concessione di 11.844 unità di azioni soggette a restrizioni (RSU) completamente maturate. Le RSU maturano e saranno liquidate in azioni della Classe A dell’emittente senza corrispettivo in denaro ($0). Dopo questa operazione, il sig. Cohen detiene effettivamente 103.760 azioni. La concessione delle RSU diventa effettiva al completamento della vendita annunciata in precedenza dell’attività Passenger dell’emittente a Joby Aero, Inc., ai sensi di un Equity Purchase Agreement datato 1 agosto 2025. Il modulo Form 4 è stato firmato per procura dall’avvocato incaricato Melissa M. Tomkiel il 03/09/2025.

Amir Cohen, Chief Accounting Officer y director de Strata Critical Medical, Inc. (SRTA), informó la concesión el 29/08/2025 de 11.844 unidades de acciones restringidas (RSU) totalmente adquiridas. Las RSU se adquieren y se liquidarán en acciones comunes Clase A del emisor sin contraprestación en efectivo ($0). Tras esta operación, el Sr. Cohen posee de forma beneficiaria 103.760 acciones. La concesión de RSU surtirá efecto una vez completada la venta previamente divulgada del negocio Passenger del emisor a Joby Aero, Inc., conforme al Equity Purchase Agreement fechado el 1 de agosto de 2025. El Form 4 fue firmado por apoderada, Melissa M. Tomkiel, el 03/09/2025.

Amir Cohen은 Strata Critical Medical, Inc. (SRTA)의 최고회계책임자 겸 이사로서 2025-08-2911,844주의 완전 취득 제한조건부 주식단위(RSU)를 부여받았음을 보고했습니다. 해당 RSU는 취득되며 발행회사의 클래스 A 보통주로 현금 대가 없이($0) 결제됩니다. 이 거래 후 Cohen 씨는 실질적으로 103,760주를 보유하게 됩니다. RSU 부여는 발행회사가 이전에 공시한 Passenger 사업을 2025년 8월 1일자 주식매매계약(Equity Purchase Agreement)에 따라 Joby Aero, Inc.에 매각하는 절차가 완료될 때 발효됩니다. Form 4는 대리권자 Melissa M. Tomkiel에 의해 2025-09-03에 서명되었습니다.

Amir Cohen, Chief Accounting Officer et administrateur de Strata Critical Medical, Inc. (SRTA), a déclaré l’octroi le 29/08/2025 de 11 844 unités d’actions restreintes (RSU) entièrement acquises. Les RSU seront acquises et réglées en actions ordinaires de Classe A de l’émetteur sans contrepartie en numéraire ($0). À la suite de cette opération, M. Cohen détient de façon bénéficiaire 103 760 actions. L’octroi des RSU prendra effet lors de la finalisation de la vente précédemment annoncée de l’activité Passenger de l’émetteur à Joby Aero, Inc., selon un Equity Purchase Agreement daté du 1er août 2025. Le formulaire Form 4 a été signé par la mandataire Melissa M. Tomkiel le 03/09/2025.

Amir Cohen, Chief Accounting Officer und Direktor von Strata Critical Medical, Inc. (SRTA), meldete am 29.08.2025 die Gewährung von 11.844 vollständig unverfallbaren Restricted Stock Units (RSUs). Die RSUs verfallen und werden in Aktien der Klasse A des Emittenten ohne Barzahlung ($0) abgewickelt. Nach dieser Transaktion besitzt Herr Cohen wirtschaftlich 103.760 Aktien. Die RSU-Zuteilung wird wirksam mit dem Abschluss des zuvor offenbarten Verkaufs des Passenger-Geschäfts des Emittenten an Joby Aero, Inc. gemäß dem Equity Purchase Agreement vom 1. August 2025. Das Form 4 wurde am 03.09.2025 von der Bevollmächtigten Melissa M. Tomkiel unterzeichnet.

Positive
  • Increased insider ownership: Reporting person’s beneficial ownership rises to 103,760 shares
  • Fully vested grant: The 11,844 RSUs are fully vested and will be settled in common stock
  • Transaction tied to strategic sale: RSUs are effective upon completion of sale of Passenger business to Joby Aero, Inc.
Negative
  • None.

Insights

TL;DR: Insider received fully vested RSUs tied to a divestiture, increasing direct ownership without cash outlay.

The reported grant of 11,844 fully vested RSUs to the Chief Accounting Officer is explicitly linked to the closing of a strategic divestiture of the Passenger business to Joby Aero, Inc. Fully vested RSUs settled in common stock represent immediate equity transfer and increase the reporting person's beneficial ownership to 103,760 shares. This is a compensatory/transaction-linked grant rather than a market purchase and may reflect post-transaction compensation or retention alignment with the company's new structure.

TL;DR: Insider ownership increased through vested RSUs; transaction is non-cash and contingent on a specified sale closing.

The Form 4 discloses a non-cash acquisition of equity (11,844 RSUs) at $0 price, effective upon completion of the specified sale. The filing shows a concrete change in beneficial ownership and clarifies settlement in common stock. As reported, this is a post-transaction equity grant rather than an open-market trade, so it does not signal buying or selling intent but does increase insider alignment with shareholders numerically.

Amir Cohen, Chief Accounting Officer e membro del consiglio di amministrazione di Strata Critical Medical, Inc. (SRTA), ha ricevuto in data 29/08/2025 una concessione di 11.844 unità di azioni soggette a restrizioni (RSU) completamente maturate. Le RSU maturano e saranno liquidate in azioni della Classe A dell’emittente senza corrispettivo in denaro ($0). Dopo questa operazione, il sig. Cohen detiene effettivamente 103.760 azioni. La concessione delle RSU diventa effettiva al completamento della vendita annunciata in precedenza dell’attività Passenger dell’emittente a Joby Aero, Inc., ai sensi di un Equity Purchase Agreement datato 1 agosto 2025. Il modulo Form 4 è stato firmato per procura dall’avvocato incaricato Melissa M. Tomkiel il 03/09/2025.

Amir Cohen, Chief Accounting Officer y director de Strata Critical Medical, Inc. (SRTA), informó la concesión el 29/08/2025 de 11.844 unidades de acciones restringidas (RSU) totalmente adquiridas. Las RSU se adquieren y se liquidarán en acciones comunes Clase A del emisor sin contraprestación en efectivo ($0). Tras esta operación, el Sr. Cohen posee de forma beneficiaria 103.760 acciones. La concesión de RSU surtirá efecto una vez completada la venta previamente divulgada del negocio Passenger del emisor a Joby Aero, Inc., conforme al Equity Purchase Agreement fechado el 1 de agosto de 2025. El Form 4 fue firmado por apoderada, Melissa M. Tomkiel, el 03/09/2025.

Amir Cohen은 Strata Critical Medical, Inc. (SRTA)의 최고회계책임자 겸 이사로서 2025-08-2911,844주의 완전 취득 제한조건부 주식단위(RSU)를 부여받았음을 보고했습니다. 해당 RSU는 취득되며 발행회사의 클래스 A 보통주로 현금 대가 없이($0) 결제됩니다. 이 거래 후 Cohen 씨는 실질적으로 103,760주를 보유하게 됩니다. RSU 부여는 발행회사가 이전에 공시한 Passenger 사업을 2025년 8월 1일자 주식매매계약(Equity Purchase Agreement)에 따라 Joby Aero, Inc.에 매각하는 절차가 완료될 때 발효됩니다. Form 4는 대리권자 Melissa M. Tomkiel에 의해 2025-09-03에 서명되었습니다.

Amir Cohen, Chief Accounting Officer et administrateur de Strata Critical Medical, Inc. (SRTA), a déclaré l’octroi le 29/08/2025 de 11 844 unités d’actions restreintes (RSU) entièrement acquises. Les RSU seront acquises et réglées en actions ordinaires de Classe A de l’émetteur sans contrepartie en numéraire ($0). À la suite de cette opération, M. Cohen détient de façon bénéficiaire 103 760 actions. L’octroi des RSU prendra effet lors de la finalisation de la vente précédemment annoncée de l’activité Passenger de l’émetteur à Joby Aero, Inc., selon un Equity Purchase Agreement daté du 1er août 2025. Le formulaire Form 4 a été signé par la mandataire Melissa M. Tomkiel le 03/09/2025.

Amir Cohen, Chief Accounting Officer und Direktor von Strata Critical Medical, Inc. (SRTA), meldete am 29.08.2025 die Gewährung von 11.844 vollständig unverfallbaren Restricted Stock Units (RSUs). Die RSUs verfallen und werden in Aktien der Klasse A des Emittenten ohne Barzahlung ($0) abgewickelt. Nach dieser Transaktion besitzt Herr Cohen wirtschaftlich 103.760 Aktien. Die RSU-Zuteilung wird wirksam mit dem Abschluss des zuvor offenbarten Verkaufs des Passenger-Geschäfts des Emittenten an Joby Aero, Inc. gemäß dem Equity Purchase Agreement vom 1. August 2025. Das Form 4 wurde am 03.09.2025 von der Bevollmächtigten Melissa M. Tomkiel unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cohen Amir

(Last) (First) (Middle)
C/O STRATA CRITICAL MEDICAL, INC.
31 HUDSON YARDS, 14TH FLOOR

(Street)
NEW YORK NY 10001

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A common stock, $0.0001 par value per share 08/29/2025 A 11,844(1) A $0 103,760 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of fully vested Restricted Stock Units ("RSUs") effective upon the completion of the Issuer's previously announced sale of its Passenger business to Joby Aero, Inc. pursuant to that certain Equity Purchase Agreement, dated as of August 1, 2025. The RSUs will be settled in shares of the Issuer's common stock.
Remarks:
/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Amir Cohen (SRTA) report on Form 4?

He reported a grant of 11,844 fully vested RSUs on 08/29/2025, settled in Class A common stock at $0.

How many shares does Amir Cohen beneficially own after the transaction?

Following the reported transaction he beneficially owns 103,760 shares.

Why were the RSUs granted to Amir Cohen?

The RSU grant is effective upon completion of the issuer's sale of its Passenger business to Joby Aero, Inc., per the Equity Purchase Agreement dated August 1, 2025.

Was this a market purchase or a compensatory grant?

The filing describes a grant of fully vested RSUs to be settled in common stock, indicating a non-market, compensatory/transaction-linked grant.

Who signed the Form 4 and when?

The Form 4 was signed by attorney-in-fact Melissa M. Tomkiel on 09/03/2025.
Blade Air Mobility Inc

NASDAQ:BLDE

BLDE Rankings

BLDE Latest News

BLDE Latest SEC Filings

BLDE Stock Data

374.17M
64.57M
11.01%
75.83%
3.05%
Airports & Air Services
Air Transportation, Nonscheduled
Link
United States
NEW YORK